Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons
Chantel Kowalchuk, Pruntha Kanagasundaram, Denise D. Belsham, et al.
Psychoneuroendocrinology (2019) Vol. 104, pp. 42-48
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
David R. Goldsmith, Mark Hyman Rapaport
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 84
Schizophrenia: a disorder of broken brain bioenergetics
Nicholas Henkel, Xiajoun Wu, Sinead M. O’Donovan, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 5, pp. 2393-2404
Closed Access | Times Cited: 56
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 49
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Raghunath Singh, Nicolette Stogios, Emily R. Smith, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 30
Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia
Tyler R. Prestwood, Roshanak Asgariroozbehani, Sally Wu, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113101-113101
Open Access | Times Cited: 39
Allyl isothiocyanate, a TRPA1 agonist, protects against olanzapine-induced hypothalamic and hepatic metabolic aberrations in female mice
Rupinder Kaur Sodhi, Hemant Kumar, Raghunath Singh, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116074-116074
Closed Access | Times Cited: 5
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 36
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
Naomi Elyse Omori, Mantas Kazimieras Malys, Geoffrey Hubert Woo, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
Insulin signalling in hypothalamic neurones
Denise D. Belsham, Prasad S. Dalvi
Journal of Neuroendocrinology (2020) Vol. 33, Iss. 4
Closed Access | Times Cited: 24
Opposing effects of clozapine and brexpiprazole on β-aminoisobutyric acid: Pathophysiology of antipsychotics-induced weight gain
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Life Sciences (2020) Vol. 247, pp. 117442-117442
Closed Access | Times Cited: 20
Optogenetic Control of Spine-Head JNK Reveals a Role in Dendritic Spine Regression
Patrik Hollós, Jismi M. John, Jukka V. Lehtonen, et al.
eNeuro (2020) Vol. 7, Iss. 1, pp. ENEURO.0303-19.2019
Open Access | Times Cited: 18
Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons
Chantel Kowalchuk, Pruntha Kanagasundaram, William Brett McIntyre, et al.
Psychoneuroendocrinology (2019) Vol. 109, pp. 104400-104400
Closed Access | Times Cited: 19
Role of TRPV1/TRPV3 channels in olanzapine-induced metabolic alteration: Possible involvement in hypothalamic energy-sensing, appetite regulation, inflammation and mesolimbic pathway
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Toxicology and Applied Pharmacology (2020) Vol. 402, pp. 115124-115124
Closed Access | Times Cited: 16
Network pharmacology-based exploration of therapeutic mechanism of Liu-Yu-Tang in atypical antipsychotic drug-induced metabolic syndrome
Ningning Li, Siying Xiang, Xin-Xin Huang, et al.
Computers in Biology and Medicine (2021) Vol. 134, pp. 104452-104452
Closed Access | Times Cited: 14
Serum hepcidin / ferroportin levels in bipolar disorder and schizophrenia
İlkay Keleş Altun, Murat İlhan Atagün, Ali Erdoğan, et al.
Journal of Trace Elements in Medicine and Biology (2021) Vol. 68, pp. 126843-126843
Closed Access | Times Cited: 14
Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up
Dongmei Han, Daliang Sun, Meihong Xiu, et al.
Psychoneuroendocrinology (2021) Vol. 133, pp. 105392-105392
Closed Access | Times Cited: 13
Role of Brain-Derived Neurotrophic Factor in Anxiety or Depression After Percutaneous Coronary Intervention
Bo Ning, Teng Ge, Yongqing Wu, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2921-2937
Closed Access | Times Cited: 4
Effects of Chitosan and N-Succinyl Chitosan on Metabolic Disorders Caused by Oral Administration of Olanzapine in Mice
B. Ts. Shagdarova, V. I. Melnikova, Valentina Kostenko, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2358-2358
Open Access | Times Cited: 1
His452Tyr polymorphism in the human 5-HT2A receptor affects clozapine-induced signaling networks revealed by quantitative phosphoproteomics
Sandra M. Martín‐Guerrero, Paula Alonso-Batan, Alba Iglesias, et al.
Biochemical Pharmacology (2021) Vol. 185, pp. 114440-114440
Closed Access | Times Cited: 9
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study
Masaru Nakamura, Takahiko Nagamine
International Clinical Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 162-167
Closed Access | Times Cited: 9
Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways
Ting Cao, Shuangyang Zhang, Qian Chen, et al.
Schizophrenia Research (2023) Vol. 260, pp. 12-22
Closed Access | Times Cited: 3
Olanzapine Ameliorates Ischemic Stroke-like Pathology in Gerbils and H2O2-Induced Neurotoxicity in SH-SY5Y Cells via Inhibiting the MAPK Signaling Pathway
Md Sadikul Islam, Ha-Young Shin, Yeo-Jin Yoo, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1697-1697
Open Access | Times Cited: 5
Clozapine Suppresses the Gene Expression and the Production of Cytokines and Up-Regulates Cyclooxygenase 2 mRNA in Human Astroglial Cells
Yael Yuhas, Shai Ashkenazi, Eva Berent, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1703-1703
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top